Continuous electroencephalography predicts delayed cerebral ischemia after subarachnoid hemorrhage: A prospective

Eric S Rosenthal1,2, Siddharth Biswal1,2, Sahar F Zafar1,2

  • 1Division of Neurocritical Care and Emergency Neurology, Massachusetts General Hospital, Boston, MA.

Annals of Neurology
|April 17, 2018
PubMed

Insights

Continuous electroencephalography (cEEG) accurately predicts delayed cerebral ischemia (DCI) in subarachnoid hemorrhage (SAH) patients. This neurocritical care tool can help identify high-risk individuals for targeted interventions and clinical trials.

Area of Science:

  • Neuroscience
  • Critical Care Medicine
  • Neurology

Background:

  • Delayed cerebral ischemia (DCI) is a significant complication following subarachnoid hemorrhage (SAH).
  • Current neurocritical care strategies aim to prevent DCI, but interventions carry risks and require careful patient selection.
  • Retrospective studies suggest continuous electroencephalography (cEEG) measures may predict DCI, but rigorous prospective validation is lacking.

Purpose of the Study:

  • To prospectively assess the accuracy of cEEG in predicting DCI after SAH.
  • To establish the diagnostic performance of specific cEEG measures for DCI risk stratification.
  • To provide evidence for using cEEG to guide interventions and clinical trial enrollment in SAH patients.

Main Methods:

  • Prospective cohort study involving high-grade, nontraumatic SAH patients.
  • Index test: prospective reporting of prespecified cEEG alarms (e.g., decreasing alpha variability, alpha-delta ratio, focal slowing, epileptiform abnormalities).
  • Reference standard: DCI confirmed by blinded, adjudicated review; analysis using multistate survival and adjusted for baseline risk.

Main Results:

  • cEEG monitoring was performed in 103 eligible SAH patients (mean duration 7.7 days).
  • EEG alarms were detected in 96.2% of patients who subsequently developed DCI versus 19.6% of those who did not.
  • Prespecified EEG findings demonstrated high sensitivity and specificity for DCI prediction across low and high baseline risk groups.

Conclusions:

  • Prospective cEEG monitoring accurately predicts DCI in SAH patients.
  • Specific cEEG findings, particularly late-onset epileptiform abnormalities, show strong predictive value.
  • cEEG can potentially optimize the targeting of therapies to SAH patients at highest risk for secondary brain injury.
Abstract

Related Concept Videos

Uncertainty in Measurement: Accuracy and Precision03:37

Uncertainty in Measurement: Accuracy and Precision

Scientists typically make repeated measurements of a quantity to ensure the quality of their findings and to evaluate both the precision and the accuracy of their results. Measurements are said to be precise if they yield very similar results when repeated in the same manner. A measurement is considered accurate if it yields a result that is very close to the true or the accepted value. Precise values agree with each other; accurate values agree with a true value. 
104.7K
Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
600
Improving Translational Accuracy02:07

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
15.0K
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
378
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
443
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
610